BillionToOne, Inc. (BLLN) stock: New Study Shows 94.4% Sensitivity in Prenatal Genetic Screening

TLDR BLLN stock falls 4.54% as BillionToOne reports strong prenatal screening data. New study gives BillionToOne 94.4% sensitivity in general-risk pregnancies. Unity Fetal Risk Screen posts 99.5% specificity and over 99.9% negative value. BillionToOne expands prenatal screening after strong results from nine U.S. sites. BLLN shares remain under pressure as the company adds new clinical [...]

The post BillionToOne, Inc. (BLLN) stock: New Study Shows 94.4% Sensitivity in Prenatal Genetic Screening appeared first on Blockonomi.